Results(4720)
An observational study utilising data from the US Tysabri TOUCH programme and select EU MS Registries to estimate the risk of progressive multifocal leukoencephalopathy (PML) and other serious opportunistic infections among patients who were exposed to an MS disease modifying treatment prior to treatment with Tysabri
United States
EU PAS number:
EUPAS19800
First published:
18/05/2026
Study
Finalised
Prospective, international, non-interventional study to assess the short- and long-term safety and effectiveness of adult patients with relapsed or refractory B cell acute lymphoblastic leukemia receiving Aucatzyl® treatment (AUTO1-LT2)
European Union
United States
EU PAS number:
EUPAS1000001004
First published:
18/05/2026
Study
Planned
Non-Interventional Post-Authorisation Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines (EV-010)
France
Germany
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS48390
First published:
13/05/2026
Study
Ongoing
Auria Clinical Informatics (FinOMOP)
Biobank
Hospital inpatient records
Other
Finland
First published:
13/05/2026
Data source
Human
Record completeness: 94%
Post-authorisation observational safety study to examine the effectiveness of risk minimization measures in place in persons with an Anapen® prescription (PASS 21-08)
France
EU PAS number:
EUPAS1000000972
First published:
13/05/2026
Study
Planned
Long-term, Non-interventional Study of Recipients of Yescarta® for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma, and Follicular Lymphoma
Austria
Canada
Czechia
France
Germany
Israel
Italy
Netherlands
Poland
Portugal
Spain
Switzerland
United Kingdom
United States
EU PAS number:
EUPAS32539
First published:
13/05/2026
Study
Ongoing
DARWIN EU® - Time to onset of thromboembolic events in adults with selected types of cancer
Belgium
Denmark
Estonia
Finland
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000814
First published:
13/05/2026
Study
Finalised
TARGET-EU: Effectiveness of BNT162b2 mRNA COVID-19 vaccine in healthy individuals or with stable pre-existing medical conditions against SARS-CoV-2 infection
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000995
First published:
12/05/2026
Study
Ongoing
Data Integration Center (DIZ), University Hospital Carl Gustav Carus Dresden
Germany
First published:
12/05/2026
Institution
Hospital/Clinic/Other health care facility
HARMONY Alliance Foundation
Austria
Belgium
Brazil
Canada
Czechia
Denmark
France
Germany
Greece
Italy
Netherlands
Poland
Qatar
Singapore
Spain
Sweden
Switzerland
United Kingdom
United Kingdom (Northern Ireland)
First published:
12/05/2026
Institution
Not-for-profit
Patient organisation/association
Institut Municipal d'Assistència Sanitària Information System / Hospital del Mar / PSMAR / (Hospital del Mar Information System)
Cancer registry
Hospital inpatient records
Hospital outpatient visit records
Primary care medical records
Spain
First published:
12/05/2026
Data source
Human
Record completeness: 100%
UK National Neonatal Research Database
Other
Isle of Man
United Kingdom
First published:
12/05/2026
Data source
Human
Record completeness: 94%
DARWIN EU® - Capturing obesity in DARWIN EU
Belgium
Croatia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Italy
Netherlands
Norway
Portugal
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000820
First published:
12/05/2026
Study
Planned
TARGET-EU: Clinical benefit of bevacizumab in metastatic colorectal cancer
Netherlands
EU PAS number:
EUPAS1000000996
First published:
11/05/2026
Study
Ongoing
Center for Public Health Research (CESP), University of Milan Bicocca
Italy
First published:
11/05/2026
Institution
Educational Institution
ENCePP partner
Implementation of controlled access to and distribution of medicinal products in European Union (CONTROL-EU)
Austria
Greece
Latvia
Netherlands
Portugal
Slovenia
Spain
Sweden
EU PAS number:
EUPAS1000000313
First published:
11/05/2026
Study
Finalised
Danny Platform
Death registry
Drug registry
Hospital inpatient records
Other
Pharmacy dispensing records
Primary care medical records
Bulgaria
Croatia
Poland
Romania
Serbia
Slovenia
Spain
First published:
11/05/2026
Data source
Human
Record completeness: 90%
COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER)
Australia
Bulgaria
Canada
Colombia
Croatia
Cyprus
Denmark
Germany
Greece
Hong Kong
Italy
Korea, Republic of
Malaysia
Mexico
New Zealand
Nigeria
Philippines
Romania
Singapore
Slovakia
Slovenia
South Africa
United Kingdom
United States
EU PAS number:
EUPAS39096
First published:
08/05/2026
Study
Ongoing
Post Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine
Italy
Netherlands
Norway
Spain
United Kingdom
EU PAS number:
EUPAS41623
First published:
08/05/2026
Study
Finalised
Retrospective analysis of adolescent patients suffering from hereditary angioedema treated with berotralstat in Europe: patients’ and treatment characteristics
Belgium
France
Germany
Italy
Spain
United Kingdom
EU PAS number:
EUPAS1000000997
First published:
08/05/2026
Study
Planned
A Post-Authorization Safety Study of Guillain-Barré Syndrome (GBS) Following ABRYSVOTM Among Older Adults in the United States (C3671031)
United States
EU PAS number:
EUPAS1000000753
First published:
08/05/2026
Study
Planned
EMR200098_008: Prospective and retrospective, single-cohort, multicenter observational long-term study in short children born small for gestational age (SGA) after treatment with Saizen® or with other recombinant human growth hormone (r-hGH) products (SALTO)
France
Germany
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS16520
First published:
08/05/2026
Study
Discontinued
id.DRIVE surveillance study of respiratory pathogens in adults hospitalised for severe acute respiratory infection (SARI) across Europe
France
Germany
Italy
Spain
United Kingdom
EU PAS number:
EUPAS1000000012
First published:
08/05/2026
Study
Ongoing
id.DRIVE study of brand-specific respiratory syncytial virus (RSV) vaccine effectiveness in Europe
France
Germany
Italy
Spain
United Kingdom
EU PAS number:
EUPAS1000000035
First published:
08/05/2026
Study
Ongoing
A regulatory non-interventional study to monitor the safety and efficacy of JARDIANCE® (Empagliflozin 10 mg) in Korean patients with Chronic Kidney Disease (CKD)
Korea, Republic of
EU PAS number:
EUPAS107293
First published:
08/05/2026
Study
Finalised
An Observational Study of Ocrelizumab Treated Patients with Multiple Sclerosis to Determine the Incidence and Mortality Rates of Breast Cancer and All Malignancies (VERISMO Study)
Germany
United States
EU PAS number:
EUPAS30752
First published:
08/05/2026
Study
Ongoing
Aarhus University & Aarhus University Hospital DEPARTMENT OF CLINICAL EPIDEMIOLOGY
Denmark
First published:
08/05/2026
Institution
Educational Institution
Safety and effectiveness of RZV in adults ≥18 years of age with Systemic lupus erythematosus (SLE) or Multiple sclerosis (MS) (EPI-ZOSTER-041 VS US DB 215104)
United States
EU PAS number:
EUPAS107073
First published:
08/05/2026
Study
Ongoing
Post-Approval Observational Cohort Study to Evaluate the Safety of the COMIRNATY 2023-2024 Formula in the United States
United States
EU PAS number:
EUPAS108135
First published:
06/05/2026
Study
Finalised
Global Registry For Novel Therapies In Bone & Endocrine Conditions (GloBE-Reg)
Disease registry
Argentina
Armenia
Australia
Belgium
Brazil
Bulgaria
China
Czechia
France
Georgia
Germany
Greece
Hong Kong
Italy
Korea, Republic of
Malaysia
Poland
Portugal
Saudi Arabia
Slovenia
Sri Lanka
Sweden
United Kingdom
United States
First published:
06/05/2026
Data source
Human
Record completeness: 93%
The UK-Irish Atopic Eczema Systemic Therapy Register
Disease registry
Ireland
United Kingdom
First published:
06/05/2026
Data source
Human
Record completeness: 77%
DARWIN EU® - Enabling pregnancy and mother-child research in DARWIN EU® Data Network - PeriNet
Croatia
Denmark
Finland
France
Germany
Hungary
Netherlands
Norway
Portugal
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000812
First published:
06/05/2026
Study
Ongoing
Croatia National Public Health Information System (Nacionalni javnozdravstveni informacijski sustav)
Administrative healthcare records (e.g., claims)
Birth registry
Cancer registry
Death registry
Diagnostic tests or procedures reimbursement
Disease registry
Emergency care discharge records
Hospital discharge records
Hospital inpatient records
Hospital outpatient visit records
Induced terminations registry
Other
Primary care medical records
Registration with healthcare system
Specialist ambulatory care records
Vaccination registry
Croatia
First published:
06/05/2026
Data source
Human
Record completeness: 97%
Norwegian Linked Health registry at University of Oslo, Pregnancy cohort
Birth registry
Hospital inpatient records
Hospital outpatient visit records
Pharmacy dispensing records
Primary care medical records
Norway
First published:
06/05/2026
Data source
Human
Record completeness: 93%
UK Biobank
Biobank
Death registry
Other
United Kingdom
First published:
05/05/2026
Data source
Human
Record completeness: 97%
A study to assess utilisation and safety of Glycopyrronium Bromide 1mg/5ml Oral Solution as licensed for symptomatic treatment of severe sialorrhoea in children and adolescents aged 3 years and older with chronic neurological disorders in the UK
United Kingdom
EU PAS number:
EUPAS103644
First published:
05/05/2026
Study
Finalised
Clinical Practice Research Datalink
Birth registry
Hospital discharge records
Other
Primary care medical records
United Kingdom
First published:
05/05/2026
Data source
Human
Record completeness: 94%
Compare data sources
Compare data sources